MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-16-2022
Global Cord Blood Corporation ROCE Ratio 2011-2026 | CO
Annual ROCE Ratio Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.48 | 12.43 | 14.38 | 6.41 | 5.21 | 7.02 | 4.34 | 6.35 | 7.17 | 7.89 | 8.28 | 9.43 |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.38 | 4.34 | 8.45 |
Quarterly ROCE Ratio Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 3.46 | 6.91 | 6.91 | 3.46 | 6.82 | 6.72 | 6.72 | 3.36 | 7.3 | 7.87 | 7.87 | 3.94 | 7.14 | 6.4 | 6.4 | 3.2 | 5.77 | 5.13 | 5.13 | 2.57 | 5.7 | 6.27 | 6.27 | 3.13 | 6.39 | 6.52 | 6.52 | 3.26 | 7.12 | 7.72 | 7.72 | 3.86 | 7.91 | 8.11 | 11.64 | 7.58 | 11.62 | 11.61 | 11.85 | 10.71 | 13.53 | 12.96 | 12.6 | 13.1 | 3.48 | - | 3.4 |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.53 | 2.57 | 7.04 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
RadNet
RDNT
|
5.69 | $ 56.78 | -4.44 % | $ 4.27 B |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 30.52 | -4.12 % | $ 1.55 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Neuronetics
STIM
|
-140.48 | $ 1.4 | 4.89 % | $ 92.3 M | USA |
 |
Sotera Health Company
SHC
|
70.91 | $ 13.26 | -2.1 % | $ 3.77 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
|
Biodesix
BDSX
|
-41.6 | $ 14.18 | -2.91 % | $ 1.84 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.16 | 0.87 % | $ 6.32 M | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.6 | -2.18 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | - | - | $ 2.68 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M |  China |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 23.99 | -2.87 % | $ 666 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 158.77 | -3.85 % | $ 7.87 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 195.86 | -1.16 % | $ 21.7 B | USA |
 |
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
-36.38 | $ 8.45 | - | $ 33.7 M | Israel |
 |
Waters Corporation
WAT
|
7.05 | $ 290.62 | -3.31 % | $ 17.3 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
PerkinElmer
PKI
|
4.92 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
-365.72 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 164.81 | -2.71 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 8.79 | -3.93 % | $ 1.91 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 6.41 | -12.43 % | $ 380 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 266.15 | -0.83 % | $ 22.1 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.45 | -1.68 % | $ 269 M | USA |
 |
Psychemedics Corporation
PMD
|
-43.78 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-52.81 | $ 25.64 | -5.75 % | $ 33.3 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 16.82 | -3.72 % | $ 896 M | USA |
 |
Quotient Limited
QTNT
|
232.42 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
11.41 | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
376.98 | - | 5.66 % | $ 22.7 M | Britain |
 |
VolitionRx Limited
VNRX
|
108.5 | $ 0.2 | 1.08 % | $ 19.2 M |  Singapore |